EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation

Li Zhong, Runhong Zhou, Lin Zhu, Hong Yan, Shuofeng Yuan, Kelvin Kai-Wang To, Na Liu, Pui Wang, Zhiwei Chen, Zongwei Cai

Acta Pharmaceutica Sinica B · 2026-11

DOI: 10.1016/j.apsb.2026.11.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Li Zhong und 9 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhong, L., Zhou, R., Zhu, L., Yan, H., Yuan, S., To, K. K., Liu, N., Wang, P., Chen, Z., & Cai, Z. (2026). Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.014

Vancouver

Zhong L, Zhou R, Zhu L, Yan H, Yuan S, To KK, et al. Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.11.014

BibTeX
@article{Zhong2026,
  author = {Zhong, Li and Zhou, Runhong and Zhu, Lin and Yan, Hong and Yuan, Shuofeng and To, Kelvin Kai-Wang and Liu, Na and Wang, Pui and Chen, Zhiwei and Cai, Zongwei},
  title = {Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  doi = {10.1016/j.apsb.2026.11.014}
}
Kostenlos starten →